Aurora Therapeutics secures $16 million seed funding from Menlo Ventures to develop personalized gene editing therapies for rare diseases.
Amount Raised
$16 Million
Round Type
Seed
BostonBiotechnologyHealth CareGeneticsTherapeuticsInvestors
Description
Aurora Therapeutics has officially launched with a $16 million seed financing from Menlo Ventures. Founded by CRISPR pioneers Jennifer Doudna and Fyodor Urnov, the company aims to address rare genetic mutations at scale. Their platform will leverage modular gene editors and new regulatory pathways. This funding will help transform personalized gene editing into a scalable model for millions of patients.
Quick answer
Aurora Therapeutics raised $16 Million in a Seed round, dated January 9, 2026. Investors: Menlo Ventures. Aurora Therapeutics is based in Boston, Massachusetts, United States.
- How much did Aurora Therapeutics raise?
- Aurora Therapeutics raised $16 Million in a Seed round on January 9, 2026.
- Who invested in Aurora Therapeutics?
- Menlo Ventures is named as investors in this round.
- What does Aurora Therapeutics do?
- Aurora Therapeutics is a biotechnology company focused on developing personalized gene editing therapies for patients with rare diseases.
- Where is Aurora Therapeutics based and how big is it?
- Aurora Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 11 employees.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Aurora Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Sangamo Therapeutics raised $17M (Post-IPO Equity) on February 4, 2026.
- Altesa raised $75M (Series B) on February 19, 2026.
- Lario Therapeutics raised $2.4M (Grant) on February 19, 2026.
- Sift Biosciences raised $3.7M (Pre-Seed) on February 18, 2026.
- Korsana Biosciences raised $175M (Series A) on February 18, 2026.
- Faeth Therapeutics raised $200M (Post-IPO Equity) on February 18, 2026.
Who to call at Aurora Therapeutics, and when
A new round usually means Aurora Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aurora Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aurora Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aurora Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aurora Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Aurora Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.